C14H15N5O6S2
Neat
413.43
178422-45-2; Cefdinir Impurity 4; 2-[[(2Z)-2-(2-amino-1, 3-thiazol-4-yl)-2-hydroxyiminoacetyl]amino]-2-(5-methyl-7-oxo-1, 2, 4, 5-tetrahydrofuro[3, 4-d][1, 3]thiazin-2-yl)acetic acid; DTXSID40747023; (Z)-2-(2-(2-aminothiazol-4-yl)-2-(hydroxyimino)acetamido)-2-(5-methyl-7-oxo-1, 2, 5, 7-tetrahydro-4H-furo[3, 4-d][1, 3]thiazin-2-yl)acetic acid; {[(2Z)-2-(2-Amino-1, 3-thiazol-4-yl)-2-(hydroxyimino)acetyl]amino}(5-methyl-7-oxo-1, 2, 5, 7-tetrahydro-4H-furo[3, 4-d][1, 3]thiazin-2-yl)acetic acid; 2(R)-2-[(Z)-2-(Aminothiazol-4-yl)-2-(hydroxyimino)acetamido)]-2-[(2RS, 5RS)-5-methyl-7-oxo-2, 4, 5 and 7-te
2-[[(2Z)-2-(2-amino-1, 3-thiazol-4-yl)-2-hydroxyiminoacetyl]amino]-2-(5-methyl-7-oxo-1, 2, 4, 5-tetrahydrofuro[3, 4-d][1 and 3]thiazin-2-yl)acetic acid
InChI=1S/C14H15N5O6S2/c1-4-5-2-26-11(18-7(5)13(23)25-4)9(12(21)22)17-10(20)8(19-24)6-3-27-14(15)16-6/h3-4,9,11,18,24H,2H2,1H3,(H2,15,16)(H,17,20)(H,21,22)/b19-8-